Interleukin-6 promoter polymorphism at position - 174 in biopsy-proven patients with erythema nodosum from a defined population

Clinical and Experimental Rheumatology

Volumn 26, Issue 3 SUPPL. 49, 2008, Pages

  Amoli, M M ^a,b   Miranda Filloy, J A ^c   Fernandez Diaz, M L ^c   Martin, J ^d   Ollier, W E R ^a   Gonzalez Gay, Miguel A ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HOSPITAL XERAL CALDE   (Spain)

^d CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GUANINE; INTERLEUKIN 6;

ALLELE; BIOPSY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTERITIS; ERYTHEMA NODOSUM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SARCOIDOSIS;

CASE-CONTROL STUDIES; ERYTHEMA NODOSUM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; LECTINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 52049095315     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. GONZALEZ-GAY MA, GARCIA-PORRUA C, PUJOL RM, SALVARANI C: Erythema nodosum: A clinical approach. Clin Exp Rheumatol 2001; 19: 365-8.
2. MERT A, KUMBASAR H, OZARAS R, ERTEN S, TASLI L, TABAK F, OZTURK R: Erythema nodosum: An evaluation of 100 cases. Clin Exp Rheumatol 2007; 25: 563-70.
3. AMOLI MM, DONN RA, THOMSON W et al.: Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy-proven erythema nodosum: J Rheumatol 2002; 29: 1671-3.
4. AMOLI MM, LLORCA J, GOMEZ-GIGIREY A et al.: E-selectin polymorphism in erythema nodosum secondary to sarcoidosis. Clin Exp Rheumatol 2004; 22: 230-2.
5. AMOLI MM, MARTIN J, MIRANDA-FILLOY JA, GARCIA-PORRUA C, OLLIER WE, GONZALEZ-GAY MA: Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura. Clin Exp Rheumatol 2007; 25 (Suppl. 44): 56-9.
6. GARCIA-PORRUA C, GONZALEZ-GAY MA, VAZQUEZ-CARUNCHO M et al.: Erythema nodosum: Etiologic and predictive factors in a defined population. Arthritis Rheum 2000; 43: 584-92.
7. AMOLI MM, THOMSON W, HAJEER AH et al.: HLA-DRB1 associations in biopsy-proven erythema nodosum. J Rheumatol 2001; 28: 2660-2.
8. MAVER A, MEDICA I, SALOBIR B, SABOVIC M, TERCELJ M, PETERLIN B: Polymorphisms in genes coding for mediators in the interleukin cascade and their effect on susceptibility to sarcoidosis in the Slovenian population. Int J Mol Med 2007; 20: 385-90.
9. GRUTTERS JC, SATO H, PANTELIDIS P et al.: Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 20-7.
10. AMOLI MM, LOPEZ-AGREDA H, SUAREZ-AMOR O, MARTIN J, OLLIER WE, GONZALEZ-GAY MA: Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defined population. Clin Exp Rheumatol 2007; 25: 624-6.